The FDAs grace period for manufacturers to stop producing and selling compounded tirzepatide is over, and the cut-off date for semaglutide is May 22
Revised: 1/2026 Full Prescribing Information WARNING: RISK OF THYROID C-CELL TUMORS In rodents, semaglutide causes dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures
[DOI] [PubMed] [Google Scholar] 14.Abati S., Sandri G.F., Finotello L., Polizzi E
Other weight-loss drugs approved for long-term use, like naltrexone/bupropion (Contrave) and phentermine/topiramate (Qsymia), suppress your appetite in different ways, like targeting nerves in the brain
and/or (4)you have objected to processing, and are waiting for that objection to be verified
Wells Fargo invested heavily in AI and digital transformation initiatives during 2025